You are here

  • Home
  • Archive
  • Volume 28, Issue 6
  • Economic Analysis of Neoadjuvant Chemotherapy Versus Primary Debulking Surgery for Advanced Epithelial Ovarian Cancer Using an Aggressive Surgical Paradigm

Article info

Article menu
Download PDFPDF
Ovarian Cancer
Economic Analysis of Neoadjuvant Chemotherapy Versus Primary Debulking Surgery for Advanced Epithelial Ovarian Cancer Using an Aggressive Surgical Paradigm

Authors

  1. Address correspondence and reprint requests to Ashley L. Cole, MPH, Division of Pharmaceutical Outcomes and Policy, UNC Eshelman School of Pharmacy, 2200 Kerr Hall, Campus Box 7573, University of North Carolina, Chapel Hill, NC 27599. E-mail: ashley.cole@unc.edu.

Citation

Cole AL, Barber EL, Gogate A, et al
Economic Analysis of Neoadjuvant Chemotherapy Versus Primary Debulking Surgery for Advanced Epithelial Ovarian Cancer Using an Aggressive Surgical Paradigm
International Journal of Gynecologic Cancer 2018;28:1077-1084.

Publication history

  • Received November 27, 2017
  • First published June 1, 2018.
Online issue publication 
February 26, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Copyright © 2018 by IGCS and ESGO